- Home
- SNSE vs SDSTW Comparison
SNSE vs SDSTW Comparison
Compare SNSE & SDSTW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SNSE | SDSTW |
|---|---|---|
| Founded | 2005 | N/A |
| Country | United States | United States |
| Employees | N/A | 8 |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.2M | 13.3M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | SNSE | SDSTW |
|---|---|---|
| Price | $30.84 | $0.23 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $72.50 | N/A |
| AVG Volume (30 Days) | ★ 611.2K | 9.6K |
| Earning Date | 01-01-0001 | 03-26-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 1.64 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.25 | $0.02 |
| 52 Week High | $36.76 | $0.30 |
Technical Indicators
Market Signals| Indicator | SNSE | SDSTW |
|---|---|---|
| Relative Strength Index (RSI) | 68.46 | 54.14 |
| Support Level | $7.94 | $0.17 |
| Resistance Level | $36.76 | $0.30 |
| Average True Range (ATR) | 3.89 | 0.03 |
| MACD | -0.27 | -0.00 |
| Stochastic Oscillator | 47.57 | 63.64 |
Price Performance
Historical ComparisonAbout SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About SDSTW Stardust Power Inc. Warrant
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).